Skip to main content

Table 2 Treatment details

From: Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection

Treatment details

Previous resection

41

Localisation

 Head

30 (73%)

 Body

7 (17%)

 Tail

4 (10%)

Resection status during primary resection

 R0

25

 R1

11

 R2

2

 Rx

2

 unknown

1

Histopathological grading

 G1

1

 G2

25

 G3

15

Age at time of primary resection [y]

 Median (range)

62 (37–75)

Adjuvant therapy after primary resection

 Chemotherapy

 

 unknown

35 (85%)

 

6 (15%)

Median duration until local recurrence after primary resection [months]

 Median (range)

17.2 (3.1–79.7)

Radiotherapy

 Median dose (range)

49.4 Gy (39.6–54)

Concomitant Chemotherapy

 Overall

41 (100%)

 Gemcitabine

37 (90%)

 5-FU/Capecitabine

4 (10%)

Intraoperative RT

 

Number of patients

15 (37%)

Median dose (range)

15 (12–15)

Resection state after CRT

 

total

4

R0

3

R1

0

R2

2

Rx

0

Negative biopsy during explorative laparoto my after CRT (number of patients)

6 (15%)

  1. CRT chemoradiation, Gy Gray, IORT intraoperative radiotherapy, RT radiotherapy.